New patented drugs exempted from price control order for 5 years

By: |
Published: January 4, 2019 8:08:42 PM

The government has exempted new drugs patented under the Indian Patent Act from the price control order for five years from the date of their marketing, according to a notification.

The DPCO fixes the prices of scheduled formulations and monitors maximum retail prices of all drugs, including the non-scheduled formulations.

The government has exempted new drugs patented under the Indian Patent Act from the price control order for five years from the date of their marketing, according to a notification. The Drugs (Prices Control) Amendment Order, 2019, by the Ministry of Chemicals and Fertilisers exempts “a manufacturer producing a new drug patented under the Indian Patent Act, 1970 (39 of 1970), for a period of five years from the date of commencement of its commercial marketing by the manufacturer in the country,” the notification said.

The provisions of DPCO 2013 shall not apply to “drugs for treating orphan diseases as decided by the Ministry of Health and Family Welfare”, it said. The DPCO fixes the prices of scheduled formulations and monitors maximum retail prices of all drugs, including the non-scheduled formulations.

The notification also mentioned that “the source of market-based data shall be the data available with the pharmaceutical market data specialising company as decided by the government, and if the government deems it necessary, it may validate such data by appropriate survey or evaluation.”

The notification said for “fixing or revising the ceiling price for formulations, the government may, if it is necessary so to do, consider market-based data available for any month, as deemed fit.”

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Adani Power appoints merchant banker to evaluate delisting proposal
2COVID-19 puts brake on e-commerce, physical retail sales; April sees massive dip in online shopping
3‘Need to adopt supply chain lens instead of geographical lens to boost domestic manufacturing’